Showing results (31-40 of 1,551) with videos related to
Sort By:
Pageof 156
Gastroenterology|August 1, 1975
Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseasesM C de Moura, S J Vernace, F ParonettoActa Medica Portuguesa|July 1, 1991
[Prognostic factors and survival model for decompensated hepatic cirrhosis]L C Ribeiro, A Saragoça, M C de MouraClinical and Experimental Immunology|June 1, 1994
Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infectionM J Covas, L A Pinto, R M VictorinoInternational Journal of Clinical & Laboratory Research|January 1, 1997
Effects of substance P on human T cell function and the modulatory role of peptidase inhibitorsM J Covas, L A Pinto, R M VictorinoClinical and Experimental Immunology|January 1, 1992
Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitizationR M Victorino, V A Maria, L A PintoJournal of Medical Virology|December 1, 1991
Inhibition of lymphocyte proliferation induced in vitro by microbial antigens in HIV-infected subjectsV A Maria, L A Pinto, R M VictorinoJournal of Medical Virology|October 1, 1995
T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individualsL A Pinto, M J Covas, R M VictorinoClinical and Experimental Immunology|November 1, 1994
Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patientsA C Jaleco, M J Covas, R M VictorinoAIDS (London, England)|December 28, 2000
Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicityR Cavaleiro, A E Sousa, A Loureiro, et al.The Journal of Rheumatology|November 1, 1989
Agranulocytosis and liver damage associated with pyrazinobutazone with evidence for an immunological mechanismV A Maria, J A da Silva, R M VictorinoPageof 156